retatrutide trial results 2025 news Clinical Trials That Redefined Medicine in Retatrutide: The Triple Agonist That's

doi: 10.1038/cr.2010.178 98 PasparakisM

Its the hormone behind the blockbuster weight-loss and diabetes drugs making headlines around the world

Ultimately, smokers may feel like they face a trading one significant health risk for another challenge dilemma

Semaglutides sales reached $21.2 billion in 2023 with an 88% increase, becoming top 3 best-selling drugs worldwide

Many attempts to get there now fill a graveyard of failed drugs, such as fen-phen in the 1990s when a single small study of this drug combination in 121 people unleashed millions of prescriptions, some leading to serious heart valve lesions that resulted in withdrawal of the drug in 1995